Insights From Survival Analyses During 12 Years of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration. (2021)
Attributed to:
INSIGHT: The Health Data Research Hub for Eye Health
funded by
ISCF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1001/jamaophthalmol.2020.5044
PubMed Identifier: 33211064
Publication URI: http://europepmc.org/abstract/MED/33211064
Type: Journal Article/Review
Volume: 139
Parent Publication: JAMA ophthalmology
Issue: 1
ISSN: 2168-6165